• David C Currow, Meera R Agar, Timothy H M To, Debra Rowett, Aine Greene, and Amy P Abernethy.
• Discipline, Palliative and Supportive Services, Flinders University , Daw Park, South Australia, Australia. david.currow@flinders.edu.au
• J Palliat Med. 2011 Mar 1;14(3):309-14.

BackgroundContinuous quality improvement is fundamental in all health care, including hospice and palliative care. Identifying and systematically reducing symptomatic adverse events is limited in hospice and palliative care because these events are mostly attributed to disease progression.ObjectivesThe aim of this study was to assess the feasibility of symptomatic adverse events in hospice and palliative care and assessing their incidence.MethodsA retrospective, consecutive cohort of notes from a specialist palliative care inpatient service was surveyed by a clinical nurse consultant for symptomatic adverse events: falls, confusion, decreased consciousness, hypo- and hyperglycaemia, urinary retention, and hypotension. Demographic and clinical factors were explored for people at higher risk.ResultsData were available on the most recent admissions of 65 people, generating >900 inpatient days. Fifty people (78%) had events precipitating admission, of whom 31 (62%) had at least one further event during admission. Eleven of 15 people who were admitted without an event experienced at least one during their admissions. Only 4 did not have an adverse event. During their stay, there were 0.13 (standard deviation [SD] = 0.19) events per patient per day. No drug-drug or drug-host events were noted. No clinical or demographic factors predicted groups at higher risk.ConclusionsThis pilot highlights the feasibility of collecting, and ubiquity of, symptomatic adverse events, and forms a baseline against which future interventions to decrease the frequency or intensity can be measured. Given the frailty of hospice and palliative patients, any adverse event is likely to accelerate irreversibly their systemic decline.

22 keywords...

hide…